Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | FBP1 | P09467 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | KDM1A | O60341 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18173489 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRAKR1C3MAPTKMT2A | |
| Styrene SCHEMBL10790042 | 0.94 | ALDH1A1 (0.58) | ALDH1A1TSHRAKR1C3MAPTKMT2A | |
| SCHEMBL250268 | 0.80 | ALDH1A1 (0.55) | ALDH1A1TSHRAKR1C3MAPTKMT2A | |
| SCHEMBL3975319 | 0.80 | ALDH1A1 (0.54) | ALDH1A1TSHRAKR1C3MAPTKMT2A | |
| SCHEMBL301021 | 0.80 | ALDH1A1 (0.54) | ALDH1A1TSHRAKR1C3MAPTKMT2A | |
| SCHEMBL301020 | 0.80 | ALDH1A1 (0.54) | ALDH1A1TSHRAKR1C3MAPTKMT2A | |
| SCHEMBL585241 | 0.80 | ALDH1A1 (0.67) | ALDH1A1TSHRAKR1C3MAPTKMT2A | |
| SCHEMBL585239 | 0.80 | ALDH1A1 (0.67) | ALDH1A1TSHRAKR1C3MAPTKMT2A | |
| SCHEMBL21055174 | 0.79 | ESR1 (0.54) | ALDH1A1MAPTKMT2ACYP2C9LMNA | |
| SCHEMBL29281424 | 0.79 | MAPT (0.44) | ALDH1A1TSHRMAPTKMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120082087-A | Preparation method of ethylene-propylene insulating flame-retardant marine power cable material | 扬州光明电缆有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-109642043-A | The closure member of container is kept for product | 唯万盛美国有限责任公司 | 2019-04-16 | — | — | CN | claimed |
| CN-101050294-A | Color changeable transparent ophthalmic lens material, and application | LIULIUMING ARTIFICIAL CRYSTALS (CN) | 2007-10-10 | — | — | CN | claimed |
| CN-116640111-A | Synthesis method of seven-membered cyclic ether compound | 苏州大学 | 2023-08-25 | — | — | CN | disclosed |
| CN-216958769-U | Low temperature resistant TPE cable | 江苏北化新橡新材料科技有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-109438190-B | Lewis acid catalyzed activation method and application of phenol derivative | 南京大学 | 2021-05-28 | — | — | CN | disclosed |
| CN-111587173-A | Bonded body of dissimilar materials and housing for housing electronic component | 三井化学株式会社 | 2020-08-25 | — | — | CN | disclosed |
| EP-3286172-B1 | LSD1 INHIBITORS AND USES THEREOF | CONSTELLATION PHARMACEUTICALS INC (US) | 2019-06-12 | — | — | EP | disclosed |
| US-20180290976-A1 | LSD1 INHIBITORS AND USES THEREOF | CONSTELLATION PHARMACEUTICALS, INC. | 2018-10-11 | — | — | US | disclosed |
| EP-3286172-A1 | LSD1 INHIBITORS AND USES THEREOF | Constellation Pharmaceuticals, Inc. (US) | 2018-02-28 | — | — | EP | disclosed |
| CN-103965818-B | Adhesive composition and bonding sheet | 日东电工株式会社 | 2017-05-31 | — | — | CN | disclosed |
| CN-102020812-A | Porous resin bead and method for producing nucleic acid using the same | NITTO DENKO CORP | 2011-04-20 | — | — | CN | disclosed |
| CN-102020813-A | Porous resin bead and method for producing nucleic acid using the same | NITTO DENKO CORP | 2011-04-20 | — | — | CN | disclosed |
| CN-101613430-A | Porous resin bead and utilize it to prepare the method for nucleic acid | NITTO DENKO CORP | 2009-12-30 | — | — | CN | disclosed |
| CN-100464999-C | Structurally supported resilient tyre and materials thereof | MICHELIN SOC TECH MICHELIN REC (FR) | 2009-03-04 | — | — | CN | disclosed |
| CN-101050294-A | Color changeable transparent ophthalmic lens material, and application | LIULIUMING ARTIFICIAL CRYSTALS (CN) | 2007-10-10 | — | — | CN | disclosed |
| CN-1324088-C | Fire retardant resin composition, method of its production, shaped articles comprising the same, and silica | NIPPON CATALYTIC CHEM IND (JP) | 2007-07-04 | — | — | CN | disclosed |
| CN-1558838-A | Structurally supported resilient tyre and materials thereof | 米其林技术公司 | 2004-12-29 | — | — | CN | disclosed |
| US-5430107-A | Binding-agent composition, coating agent containing said binding agent, and the use thereof | HERBERTS GMBH (DE) | 1995-07-04 | — | — | US | disclosed |
| US-4048420-A | ADDITION POLYMERIZATION, BUTADIENE, STYRENE, ISOPRENE, ACRYLONITRILE N | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1977-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180290976-A1 | LSD1 INHIBITORS AND USES THEREOF | KDM1B, KDM1A, KDM2A | ALDH1A1 187/4885TSHR 4232/4885AKR1C3 2059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.